ACAD:NASDAQ
ACADIA Pharmaceuticals Inc
$20.89
arrow_downward
-2.93%(-0.63) 1D
$20.80
arrow_downward
-0.43% (-0.090)todayPre-market
Closed: Jun 2, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ACAD...
Open
$21.27
High
$21.38
Low
$20.75
Mkt. cap
3.58B
Avg. vol.
1.56M
Volume
2.27K
P/E ratio
9.55
52-wk high
$28.34
52-wk low
$19.69
EPS
$2.19
Beta
0.84
Shares outstanding
171.24M
No. of employees
797
Open
$21.27
High
$21.38
Low
$20.75
Mkt. cap
3.58B
Avg. vol.
1.56M
Volume
2.27K
P/E ratio
9.55
52-wk high
$28.34
52-wk low
$19.69
EPS
$2.19
Beta
0.84
Shares outstanding
171.24M
No. of employees
797
News stories
From sources across the web
Stock Titan
·
12 hours ago
Baker funds tied to ACAD (ACAD) report RSU and stock option grants
Stock Traders Daily
·
20 hours ago
Technical Reactions to ACAD Trends in Macro Strategies
Profile
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, California. Wikipedia
About ACADIA Pharmaceuticals Inc
CEOCatherine Owen Adams
Employees797
Founded1993
HeadquartersSan Diego, California, United States
SectorBiotechnology
Websiteacadia.com
AI content may include mistakes. Learn more